Cargando…

Nutrition could prevent or promote non-alcoholic fatty liver disease: an opportunity for intervention

Manuel Romero-Gómez and colleagues discuss how diet and modifiable factors can help prevent of non-alcoholic fatty liver disease and the importance of engaging all society through awareness, education, and policy change

Detalles Bibliográficos
Autores principales:	Romero-Gómez, Manuel, Zelber-Sagi, Shira, Martín, Franz, Bugianesi, Elisabetta, Soria, Bernat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group Ltd. 2023
Materias:	Analysis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10561058/ https://www.ncbi.nlm.nih.gov/pubmed/37813416 http://dx.doi.org/10.1136/bmj-2023-075179

Ejemplares similares

Dietary strategies in non‐alcoholic fatty liver disease patients: From evidence to daily clinical practice, a systematic review
por: Hadefi, Alia, et al.
Publicado: (2023)

Predictors for advanced fibrosis in morbidly obese non-alcoholic fatty liver patients
por: Zelber-Sagi, Shira, et al.
Publicado: (2017)

Serum Malondialdehyde is Associated with Non-Alcoholic Fatty Liver and Related Liver Damage Differentially in Men and Women
por: Zelber-Sagi, Shira, et al.
Publicado: (2020)

Non-Alcoholic Steatohepatitis: Pathogenesis and Clinical Management
por: Salomone, Federico, et al.
Publicado: (2015)

High Meat Consumption Is Prospectively Associated with the Risk of Non-Alcoholic Fatty Liver Disease and Presumed Significant Fibrosis
por: Ivancovsky-Wajcman, Dana, et al.
Publicado: (2022)

Higher phenolic acid intake independently associates with lower prevalence of insulin resistance and non-alcoholic fatty liver disease
por: Salomone, Federico, et al.
Publicado: (2020)

Non-Alcoholic Fatty Liver Disease and Extra-Hepatic Cancers
por: Sanna, Claudia, et al.
Publicado: (2016)

Role of illness perception and self-efficacy in lifestyle modification among non-alcoholic fatty liver disease patients
por: Zelber-Sagi, Shira, et al.
Publicado: (2017)

European ‘NAFLD Preparedness Index’ — Is Europe ready to meet the challenge of fatty liver disease?
por: Lazarus, Jeffrey V., et al.
Publicado: (2021)

Non-alcoholic fatty liver disease: A patient guideline
por: Francque, Sven M., et al.
Publicado: (2021)

Lifestyle and Hepatocellular Carcinoma What Is the Evidence and Prevention Recommendations
por: Zelber-Sagi, Shira, et al.
Publicado: (2021)

Nutritional issues in patients with obesity and cirrhosis
por: Schiavo, Luigi, et al.
Publicado: (2018)

Role of government policy in nutrition—barriers to and opportunities for healthier eating
por: Mozaffarian, Dariush, et al.
Publicado: (2018)

Efficacy and safety of semaglutide in non-alcoholic fatty liver disease
por: Zhu, Kai, et al.
Publicado: (2023)

Serum Soluble Receptor for AGE (sRAGE) Levels Are Associated With Unhealthy Lifestyle and Nonalcoholic Fatty Liver Disease
por: Ivancovsky-Wajcman, Dana, et al.
Publicado: (2019)

Pathophysiology of Non Alcoholic Fatty Liver Disease
por: Petta, Salvatore, et al.
Publicado: (2016)

Novel glucose-lowering drugs for non-alcoholic fatty liver disease
por: Fu, Zuo-Di, et al.
Publicado: (2021)

Statin liver safety in non‐alcoholic fatty liver disease: A systematic review and metanalysis
por: Pastori, Daniele, et al.
Publicado: (2021)

Association of non-alcoholic fatty liver and metabolic-associated fatty liver with COVID-19 outcomes: A systematic review and meta-analysis
por: Jagirdhar, Gowthami Sai Kogilathota, et al.
Publicado: (2023)

Integrating social nutrition principles into the treatment of steatotic liver disease
por: Ivancovsky-Wajcman, Dana, et al.
Publicado: (2023)

Current therapies and new developments in NASH
por: Dufour, Jean-François, et al.
Publicado: (2022)

Meta-analysis reveals up-regulation of cholesterol processes in non-alcoholic and down-regulation in alcoholic fatty liver disease
por: Wruck, Wasco, et al.
Publicado: (2017)

Longitudinal decrease in platelet counts as a surrogate marker of liver fibrosis
por: Gotlieb, Neta, et al.
Publicado: (2020)

Application of artificial intelligence in non-alcoholic fatty liver disease and liver fibrosis: a systematic review and meta-analysis
por: Decharatanachart, Pakanat, et al.
Publicado: (2021)

Front-of-pack nutrition labelling to promote healthier diets: current practice and opportunities to strengthen regulation worldwide
por: Jones, Alexandra, et al.
Publicado: (2019)

Increased risk of cerebrovascular accident related to non-alcoholic fatty liver disease: a meta-analysis
por: Hu, Jianping, et al.
Publicado: (2017)

Role of Circadian Clock on the Pathogenesis and Lifestyle Management in Non-Alcoholic Fatty Liver Disease
por: Perez-Diaz-del-Campo, Nuria, et al.
Publicado: (2022)

The global fatty liver disease Sustainable Development Goal country score for 195 countries and territories
por: Lazarus, Jeffrey V., et al.
Publicado: (2023)

Banking for health: opportunities in cooperation between banking and health applying innovation from other sectors
por: Kickbusch, Ilona, et al.
Publicado: (2018)

Relationship between non-alcoholic fatty liver disease and cardiac arrhythmia: a systematic review and meta-analysis
por: Gong, Hang, et al.
Publicado: (2021)

Impact of Chronotype and Mediterranean Diet on the Risk of Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease
por: Castelnuovo, Gabriele, et al.
Publicado: (2023)

Imaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver disease
por: Gallego-Durán, Rocío, et al.
Publicado: (2016)

Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United States
por: Golabi, Pegah, et al.
Publicado: (2019)

Threat of compulsory licences could increase access to essential medicines
por: Ooms, Gorik, et al.
Publicado: (2019)

Clinical application of angiotensin receptor blockers in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis
por: Li, Yating, et al.
Publicado: (2018)

Association between non-alcoholic fatty liver disease and risk of incident heart failure: a meta-analysis of observational studies
por: Li, Wensheng, et al.
Publicado: (2022)

Non-Alcoholic Fatty Liver Disease (NAFLD) and Its Connection with Insulin Resistance, Dyslipidemia, Atherosclerosis and Coronary Heart Disease
por: Gaggini, Melania, et al.
Publicado: (2013)

Could NICE guidance on the choice of blood pressure lowering drugs be simplified?
por: Sofat, Reecha, et al.
Publicado: (2012)

Estimating global prevalence, incidence, and outcomes of non-alcoholic fatty liver disease from 2000 to 2021: systematic review and meta-analysis
por: Liu, Jiaye, et al.
Publicado: (2022)

Self care interventions could advance sexual and reproductive health in humanitarian settings
por: Logie, Carmen H, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_f9obus4mnj75i0kco3r4sj0bhb